China has published its first state-backed catalogue of costly innovative drugs to be covered by private health insurers.
If you are already a subscriber
OR sign-up for a trial access here
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.
more »